An yi wa Mara lafiya Na Farko a Nazari akan Ciwon Kan Renal

Sakin Kyauta | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Telix Pharmaceuticals Limited a yau ta sanar da cewa an yi wa majiyyaci na farko allura a cikin 'STARLITE 2' Phase II binciken na Kamfanin binciken maganin ciwon daji na Kamfanin, TLX250 (177Lu-DOTA-girentuximab), a Memorial Sloan Kettering Cancer Center (MSK) a New York. .               

Starlite 2 (NCT05239533) zai tantance ingancin TLX250 da aka yi niyya a hade da rigakafin tantanin tantanin tantanin halitta na kwayar cutar ta koda. TLX250 yana hari carbonic anhydrase IX (CA9), [1] furotin da aka bayyana sosai a cikin marasa lafiya wanda zai iya nuna ƙarancin amsa ga ciwon daji na rigakafi.[2] Manufar ita ce ƙananan allurai na radiation da aka yi niyya na iya yuwuwar shawo kan juriya na rigakafi - ko kuma “ƙananan rigakafi” ƙari kuma don haka ya sa ya fi dacewa da rigakafin cutar kansa.

Wannan binciken na Mataki na II, a cikin marasa lafiya waɗanda suka ci gaba da ci gaba bayan kafin rigakafi, za su kimanta TLX250 da aka ba da radiation a hade tare da anti-PD-1 [3] immunotherapy Opdivo®[4] (nivolumab). Mahimmin ƙarshen shine don ƙayyade aminci da ingancin haɗin gwiwa tare da TLX250 kamar yadda aka tantance ta hanyar ciwace-ciwacen da ke amsawa ga maganin Telix tare da daidaitattun kulawa na yanzu kawai. Wakilin binciken abokin binciken Telix TLX250-CDx (89Zr-DFO-girentuximab) kuma za a yi amfani da shi a cikin binciken don hoton CA9 magana. Ana sa ran binciken da mai binciken hannu ɗaya zai yi rajistar kusan marasa lafiya 30.

Babban Jami'in Kiwon Lafiya na Telix, Dokta Colin Hayward ya lura, "Haɗin kai na daidaitattun magungunan nukiliya da kuma likitan ilimin likitanci yana gudana kuma Telix yana kan gaba a cikin wannan motsi don haɓaka samfurori na musamman da kuma tsarin kulawa da haƙuri. Muna so mu nuna godiya ga Dr. Darren Feldman da tawagarsa na asibiti, da kuma marasa lafiya da za su ba da gudummawa ga wannan bincike mai zurfi. "

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...